high throughput small interfering rna rnai screening assay (Revvity)
Structured Review

High Throughput Small Interfering Rna Rnai Screening Assay, supplied by Revvity, used in various techniques. Bioz Stars score: 91/100, based on 75 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/throughput+rnai+screen/High-throughput%2C+High+Content+RNAi+Screening/pmc09856511-113-10-33
Average 91 stars, based on 75 article reviews
Images
1) Product Images from "Essential Role of Adhesion GPCR, GPR123, for Human Pluripotent Stem Cells and Reprogramming towards Pluripotency"
Article Title: Essential Role of Adhesion GPCR, GPR123, for Human Pluripotent Stem Cells and Reprogramming towards Pluripotency
Journal: Cells
doi: 10.3390/cells12020304
Figure Legend Snippet: Localization of GPR123 in hESCs and its role in colony morphology. ( A ): Immunofluorescence observation of the GPR122 expression in hESCs. Scale bar 100 μm. ( B ): TEM observation of the GPR123 localization in hESCs. Immunogold labeling (arrows) of the nucleolus ( B ) and nuclear membrane ( B’ ) with specific antibody against GPR123 (10 nm gold particles). Abbreviation: n stands for nucleus, nl—nucleolus, and nm—nuclear membrane. Inserts at the bottoms ( B , B’ ) represent GPR123 immunogold labeling at a higher resolution. Scale bar 1 μm. ( C ): Representative Western blot analyses of the GPR123 expression in hESCs (H9) and in embryonic bodies (EB) at day 1 (D1), day 10 (D10), and at day 14 (D14) EBs differentiation. n = 3. ( D ): Real-time quantitative polymerase chain reaction analysis of the relative expression of GPR123 versus GAPDH under GPR123 RNAi in hESCs. Data are shown as mean ± SEM, n = 3, with significance difference indicated with asterisks (***, p < 0.001). ( E ): Representative Western blot analysis of GPR123 in hESCs transfected with control and GPR123 RNAi, n = 3. GAPDH serve as a loading control. ( F ): Representative images depicting typical colony morphology at phase-contrast observation for the control and GPR123 RNAi–treated colonies at day 1, day 2, day 3, and day 4 of transfection. Scale bar 400 μm. ( G ): Representative images of the alkaline-phosphatase staining of control and GPR123 RNAi hESCs (H9). Scale bar 100 μm. Abbreviations: DAPI—4′,6-diamidino-2-phenylindole; hESC—human embryonic stem cell; GAPDH—glyceraldehyde-3-phosphate dehydrogenase; and RNAi—RNA interference.
Techniques Used: Immunofluorescence, Expressing, Labeling, Membrane, Western Blot, Real-time Polymerase Chain Reaction, Transfection, Control, Staining
Figure Legend Snippet: Downregulation of GPR123 abrogates human-induced pluripotent stem cells generation. ( A ): Phase-contrast observation of the typical hiPSC colonies at day 12 of the reprogramming process under the control RNAi ( A ) and GPR123 RNAi ( B ). Arrows poined to hiPSCs colonies. Scale bar 100 μm. ( C ): Representative image of the typical colonies at day 18 of the reprogramming process under the control RNAi and GPR123 RNAi. Arrows poined to hiPSCs colonies. Scale bar 100 μm. ( D ): Representative images of the alkaline-phosphatase (AP) staining of the control and GPR123 RNAi hiPSCs at day 18 of reprogramming. ( E , E’ , F , F’ ): Flow cytometry analysis of different subpopulations during the time course (at day 12 and day 18) of reprogramming in the control and GPR123 RNAi-treated groups. ( G ): Real-time quantitative polymerase chain reaction analysis of the relative expression of GPR123 in TRA-1-60+/CD44- populations (true iPSCs) and in partly reprogrammed cells (TRA-1-60+/CD44+) at day 14 in the control and GPR123 RNAi groups. Data are shown as mean ± SEM, n = 3. (H): Real-time quantitative polymerase chain reaction analysis of the GPR123 expression normalized to expression at the neo1 fibroblasts during the time-course of transduction. Data are shown as mean ± SEM, n = 3, with the significance difference indicated with asterisks (***, p < 0.001). Abbreviations: AP—alkaline phosphatase.
Techniques Used: Control, Staining, Flow Cytometry, Real-time Polymerase Chain Reaction, Expressing, Transduction
Figure Legend Snippet: Downregulation of GPR123 results in loss of pluripotency and increased expression of differentiation marker genes in hPSCs. ( A ): Real-time quantitative PCR analysis of OCT4 , NANOG , SOX2 , KLF4 , and c-MYC expression in hESCs (H9) control and GPR123 RNAi groups. Data represent relative expression to GAPDH and were normalized against the control RNAi. Results are presented as mean ± SEM ( n = 3), with significance difference indicated with asterisks ( p < 0.01 as **, p < 0.001 as ***). ( B ): Representative Western blot analyses of the pluripotent markers OCT4 and NANOG expression in hESCs (H9) treated with the control and GPR123 RNAi. ( C ): Real-time quantitative PCR analysis of the differentiation markers expression in hESCs (H9) control and GPR123 RNAi groups. Data represent relative expression to GAPDH and were normalized against the control RNAi. Results are presented as mean ± SEM ( n = 3), with significance difference indicated with asterisks ( p < 0.01 as **, p < 0.001 as ***). ( D ): Representative Western blot analyses of the differentiation markers NESTIN and VIMENTIN expression in hESCs (H9) treated with the control and GPR123 RNAi. ( E ): Real-time quantitative PCR analysis of MET genes expression in hESCs (H9) control and GPR123 RNAi groups. Data represent relative expression to GAPDH and were normalized against the control RNAi. Results are presented as mean ±SEM ( n = 3), with significance difference indicated with asterisks ( p < 0.05 as *, p < 0.001 as ***). ( F ): Representative Western blot analyses of the E-cadherin and N-cadherin expression in hESCs (H9) treated with the control and GPR123 RNAi. ( G , G’ ): Confocal immunofluorescence observation of the NANOG and E-cadherin expression in the control and GPR123 RNAi hESCs (H9). Scale bar 50 μm. ( H ): Representative confocal immunofluorescence images of E-cadherin expression in the control and GPR123 RNAi hiPSCs at day 12 of the reprogramming. Scale bar 50 μm.
Techniques Used: Expressing, Marker, Real-time Polymerase Chain Reaction, Control, Western Blot, Immunofluorescence
Figure Legend Snippet: Downregulation of GPR123 leads to accumulation of cells at the G2 phase of the cell cycle. ( A ): MODFIT analysis of the cell cycle of hESCs (H9) treated with the control and GPR123 RNAi. ( B ): Real-time quantitative PCR analysis of the cell cycle genes expression in hESCs (H9) control and GPR123 RNAi groups. Data represent relative expression to GAPDH and were normalized against the control RNAi. Results are presented as mean–SEM ( n = 3), with significance difference indicated with asterisks ( p < 0.05 as *). ( C ): Representative Western blot analyses of the CYCLIN D1, CYCLIN E, CYCLIN B1, and CYCLINA1 in control and GPR123 RNAi hESCs (H9). ( D ): Real-time quantitative PCR analysis of the CDC25A , CDC25B, and CDC25C genes expression in hESCs (H9) control and GPR123 RNAi groups. Data represent relative expression to GAPDH and were normalized against the control RNAi. Results are presented as mean –SEM ( n = 3), with significance difference indicated with asterisks ( p < 0.05 as *). ( E , F ): Flow cytometric analysis of apoptosis in hESCs (H9). ( E , F ): The hiPSCs under treatment with Control and GPR123 RNAi. ( G ): Real-time quantitative PCR analysis of the apoptosis genes expression in hESCs (H9) control and GPR123 RNAi groups. Data represent relative expression to GAPDH and were normalized against the control RNAi. Results are presented as mean –SEM ( n = 3), with significance difference indicated with asterisks ( p < 0.01 as **, p < 0.001 as ***).
Techniques Used: Control, Real-time Polymerase Chain Reaction, Expressing, Western Blot
Figure Legend Snippet: Expression and co-localization of Gαi and GPR123 in hESCs. ( A ): Real-time quantitative PCR analysis of the AC5 , PKA, CREB , STAT3 , RhoA , MAPK14 , and SMAD3 genes expression in hESCs (H9) control and GPR123 RNAi groups. Data represent relative expression to GAPDH and were normalized against the control RNAi. Results are presented as mean –SEM ( n = 3), with significance difference indicated with asterisks ( p < 0.01 as **, p < 0.001 as ***). ( B ): Representative Western blot analyses of the p-ERK (Thr202/Tyr204) and p-CREB (Ser133) in the control and GPR123 RNAi hESCs (H9). ( C ): Real-time quantitative PCR analysis of the Gα subunits expression in GPR123 RNAi hESCs (H9). Data represent relative expression to RPL13A and were normalized against expression of the Gα subunits in the control RNAi hESC line (H9). Results are presented as mean ± SEM ( n = 3), statistical significance was analyzed using Student’s t -test, p < 0.05 was considered significant and is denoted as *, p < 0.01 as **, p < 0.001 as ***. ( D ): Representative images of the Confocal immunofluorescence observation of the co-localization between Gαi with GPR123 in hESCs (H9) treated with the control RNAi (upper panel) and with GPR123 RNAi (bottom panel). Scale bar 50 μm. ( E ): TEM observation of the Gαi and GPR123 localization in hESCs. Immunogold labeling in the nucleus ( n ), nuclear membrane (nm), and in the nucleolus (nL) with specific antibodies against the Gαi (15 nm gold particles, black thick arrows) and GPR123 (10 nm gold particles, black thin arrows). An inset in the lower left corner depicts the area with both labels. Scale bar 1 μm.
Techniques Used: Expressing, Real-time Polymerase Chain Reaction, Control, Western Blot, Immunofluorescence, Labeling, Membrane
Figure Legend Snippet: GPR123 is important for wound healing of hiPSCs and ACTIN reorganization during the reprogramming process. ( A ): Graphical representation of the wound healing of hiPSCs treated with the control and GPR123 RNAi. Human iPSCs were subjected to scratch wounding from 0 h until 24 h ( n = 5). ( A’ ): Representative images of the time-lapse phase-contrast observation of the wound healing at time 0 and 24hrs. Scale bar 200 µm. ( B ): Representative images of the confocal immunofluorescent staining with Rhodamine phalloidine in the control and GPR123 RNAi hiPSCs. Scale bar 50 μm. ( C ): Representative Western blot analyses of β-ACTIN and p-FAK(Tyr 397) in hiPSCs treated with the control and GPR123 RNAi.
Techniques Used: Control, Staining, Western Blot
Related Articles
Phospho-proteomics:Article Title: Functional kinomics establishes a critical node of volume-sensitive cation-Cl − cotransporter regulation in the mammalian brain Article Snippet: .. To identify genes required for KCC3 P-Thr 991 phosphorylation, a |


